P2.04-82 Discontinuation of Anti-PD-1/PD-L1 Antibody Therapy in the Absence of Disease Progression: Clinical Outcomes in Advanced NSCLC

Autor:	M. Cerini, Gonzalo Recondo, M. Rizzi, M. Naveira, Manglio Rizzo, N. Minatta, A. Perfetti, M. Faura, M. Bluthgen, A. Kuzminin, L. Lupinacci
Rok vydání:	2019
Předmět:	Pulmonary and Respiratory Medicine Oncology medicine.medical_specialty biology business.industry Disease progression Anti pd 1 Discontinuation PD-L1 Internal medicine biology.protein Medicine business Antibody therapy
Zdroj:	Journal of Thoracic Oncology. 14:S741-S742
ISSN:	1556-0864
DOI:	10.1016/j.jtho.2019.08.1587
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::51737467c8fd008dca531a47b2ad3236 https://doi.org/10.1016/j.jtho.2019.08.1587 Zobrazit plný text záznamu